Avidity Biosciences, Inc. (RNA)
71.38
+0.08
(+0.11%)
USD |
NASDAQ |
Dec 10, 14:26
Avidity Biosciences Total Assets (Quarterly): 2.134B for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Novartis AG | 107.29B |
| Eli Lilly & Co. | 114.94B |
| Dyne Therapeutics, Inc. | 867.06M |
| Astria Therapeutics, Inc. | 271.87M |
| Intellia Therapeutics, Inc. | 925.28M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 247.94M |
| Shareholders Equity (Quarterly) | 1.886B |
| Debt to Equity Ratio | 0.0265 |
| Current Ratio | 11.57 |
| Net Debt Paydown Yield | -0.13% |